PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25439783-6	2015	RESULTS: The 4E-BP1/eIF4E ratio was adjusted to evaluate the response to rapamycin treatment in TE1 and TE2 esophageal cancer cells.	Sirolimus	73-82	N-alpha-acetyltransferase 10, NatA catalytic subunit	Homo sapiens	104-107	
25439783-7	2015	TE2 cells are sensitized to rapamycin treatment after overexpression of 4E-BP1 or knockdown of eIF4E; TE1 cells become resistant to rapamycin after knockdown of 4E-BP1 or overexpression of eIF4E.	Sirolimus	28-37	N-alpha-acetyltransferase 10, NatA catalytic subunit	Homo sapiens	0-3	
25439783-7	2015	TE2 cells are sensitized to rapamycin treatment after overexpression of 4E-BP1 or knockdown of eIF4E; TE1 cells become resistant to rapamycin after knockdown of 4E-BP1 or overexpression of eIF4E.	Sirolimus	132-141	N-alpha-acetyltransferase 10, NatA catalytic subunit	Homo sapiens	0-3	
25439783-8	2015	These data suggest that the 4E-BP1/eIF4E ratio is a determinant for the response of TE1 and TE2 cells to rapamycin treatment.	Sirolimus	105-114	N-alpha-acetyltransferase 10, NatA catalytic subunit	Homo sapiens	92-95	
25439783-9	2015	Egr-1 expression was higher in TE2 cells compared with other esophageal cancer cell lines, and its knockdown increased 4E-BP1 expression in TE2 cells, which became sensitive to rapamycin treatment.	Sirolimus	177-186	N-alpha-acetyltransferase 10, NatA catalytic subunit	Homo sapiens	140-143